サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390864

製剤開発アウトソーシング市場：世界の産業動向、シェア、規模、成長、機会、2023年～2028年予測

Formulation Development Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
製剤開発アウトソーシング市場：世界の産業動向、シェア、規模、成長、機会、2023年～2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の製剤開発アウトソーシング市場規模は2022年に226億米ドルに達しました。今後、IMARC Groupは、同市場が2028年までに337億米ドルに達し、2022年～2028年の成長率（CAGR）は6.89%に達すると予測しています。

製剤開発とは、特許性、ライフサイクル、医薬品の成功を決定するプロセスを指します。また、分析アッセイの開発や特性評価、製品の安定化や溶解性向上のための賦形剤スクリーニング、剤形開発などのプレフォーミュレーションも含まれます。製剤開発は、時間的なプレッシャーや社内リソースの不足から、しばしばアウトソーシングされます。製剤開発のアウトソーシングには、タイムラインの短縮、専門知識の利用、製品の不具合に対する追加保険など、数多くのメリットもあります。

製剤開発のアウトソーシング市場動向：

糖尿病、慢性閉塞性肺疾患（COPD）、がん、喘息、関節炎、アルツハイマー病などの慢性疾患の蔓延が、新薬の発見と開発に対する需要を喚起しています。その結果、製剤開発サービスが世界中の医薬品開発業務受託機関（CRO）に委託される主な要因のひとつとなっています。これに加えて、医薬品を開発パイプラインに通す際のリスクを克服し、時間とコストを節約する必要性も高まっています。その結果、世界の大手製薬企業やバイオテクノロジー企業は、医薬品開発プロセスの初期段階でアウトソーシングサービスと提携するようになっています。これに加えて、主要医薬品の特許切れによる新薬開発の必要性が大幅に高まっていることも、市場の成長に寄与しています。さらに、いくつかの国の企業や行政機関によるヘルスケア支出の拡大が、良好な市場見通しを生み出しています。さらに、コロナウイルス感染症（COVID-19）の流行は、伝染性感染症に対する効果的な治療法を見つけるための臨床試験の必要性にプラスの影響を与えています。このため、治療薬を開発するための研究開発（R&D）への投資が拡大しており、これが市場を牽引すると予測されています。

本レポートで扱う主な質問

  • 世界の製剤開発アウトソーシング市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19が世界の製剤開発アウトソーシング市場に与えた影響は？
  • 主要地域市場とは？
  • サービス別の市場内訳は？
  • 剤形別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の製剤開発アウトソーシング市場の構造と主なプレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 製剤開発アウトソーシングの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：サービス別

  • プレフォーミュレーションサービス
    • 市場動向
    • 主要セグメント
      • 開発・前臨床サービス
      • 分析サービス
    • 市場予測
  • 製剤最適化
    • 市場動向
    • 主要セグメント
      • フェーズi
      • フェーズII
      • フェーズIII
      • フェーズIV
    • 市場予測

第7章 市場内訳：剤形別

  • 注射剤
    • 市場動向
    • 市場予測
  • 経口剤
    • 市場動向
    • 市場予測
  • 外用
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • オンコロジー
    • 市場動向
    • 市場予測
  • 遺伝子疾患
    • 市場動向
    • 市場予測
  • 神経学
    • 市場動向
    • 市場予測
  • 感染症
    • 市場動向
    • 市場予測
  • 呼吸器
    • 市場動向
    • 市場予測
  • 循環器
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオ医薬品企業
    • 市場動向
    • 市場予測
  • 政府・学術機関
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Aizant Drug Research Solutions Private Limited
    • Catalent Inc.
    • Charles River Laboratories
    • Dr. Reddy's Laboratories Ltd.
    • Emergent BioSolutions Inc.
    • Intertek Group plc
    • Irisys LLC（Recro Pharma）
    • Laboratory Corporation of America Holdings
    • Lonza Group AG
    • Piramal Pharma Solutions
    • Quotient Sciences
    • Syngene International Limited（Biocon Limited）
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Formulation Development Outsourcing Market: Major Drivers and Challenges
  • Figure 2: Global: Formulation Development Outsourcing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Formulation Development Outsourcing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Formulation Development Outsourcing Market: Breakup by Service (in %), 2022
  • Figure 5: Global: Formulation Development Outsourcing Market: Breakup by Dosage Form (in %), 2022
  • Figure 6: Global: Formulation Development Outsourcing Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Formulation Development Outsourcing Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Formulation Development Outsourcing Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Formulation Development Outsourcing (Pre-formulation Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Formulation Development Outsourcing (Pre-formulation Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Formulation Development Outsourcing (Formulation Optimization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Formulation Development Outsourcing (Formulation Optimization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Formulation Development Outsourcing (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Formulation Development Outsourcing (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Formulation Development Outsourcing (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Formulation Development Outsourcing (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Formulation Development Outsourcing (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Formulation Development Outsourcing (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Formulation Development Outsourcing (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Formulation Development Outsourcing (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Formulation Development Outsourcing (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Formulation Development Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Formulation Development Outsourcing (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Formulation Development Outsourcing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Formulation Development Outsourcing (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Formulation Development Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Formulation Development Outsourcing (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Formulation Development Outsourcing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Formulation Development Outsourcing (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Formulation Development Outsourcing (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Formulation Development Outsourcing (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Formulation Development Outsourcing (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Formulation Development Outsourcing (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Formulation Development Outsourcing (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Formulation Development Outsourcing Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Formulation Development Outsourcing Industry: SWOT Analysis
  • Figure 89: Global: Formulation Development Outsourcing Industry: Value Chain Analysis
  • Figure 90: Global: Formulation Development Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Formulation Development Outsourcing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Formulation Development Outsourcing Market Forecast: Breakup by Service (in Million US$), 2023-2028
  • Table 3: Global: Formulation Development Outsourcing Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
  • Table 4: Global: Formulation Development Outsourcing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Formulation Development Outsourcing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Formulation Development Outsourcing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Formulation Development Outsourcing Market: Competitive Structure
  • Table 8: Global: Formulation Development Outsourcing Market: Key Players
目次
Product Code: SR112023A4747

Abstract

The global formulation development outsourcing market size reached US$ 22.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.89% during 2022-2028.

Formulation development refers to the process of determining patentability, lifecycle, and the success of the pharmaceutical product. It also involves pre-formulation, including analytical assay development and characterization, excipient screening to stabilize or enhance the solubility of the product and dosage form development. It is often outsourced due to time pressure and a lack of internal resources. Formulation development outsourcing also offers numerous benefits, such as compressing timelines, accessing expertise, and providing extra insurance against product failure.

Formulation Development Outsourcing Market Trends:

The growing prevalence of chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, asthma, arthritis, and Alzheimer's disease, is catalyzing the demand for the discovery and development of new drugs. This, in turn, represents one of the key factors resulting in the formulation development services being outsourced to contract research organizations (CROs) around the world. Besides this, there is a rise in the need to overcome the risk and save time and money involved in passing the drug through the development pipeline. As a result, leading pharmaceutical and biotechnological companies worldwide are partnering with outsourcing services in the early phases of the drug development process. This, along with a significant increase in the need to innovate novel drugs on account of the rising patent expirations of major drugs, is contributing to market growth. Furthermore, expanding healthcare expenditure by business enterprises and governing agencies of several countries is creating a favorable market outlook. Moreover, the coronavirus disease (COVID-19) outbreak has positively influenced the need for clinical trials to find an effective treatment against the contagious infection. This has resulted in extensive investments in research and development (R&D) to develop therapeutics, which is projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global formulation development outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, dosage form, application and end user.

Breakup by Service:

Pre-formulation Services

Discovery and Preclinical Services

Analytical Services

Formulation Optimization

Phase I

Phase II

Phase III

Phase IV

Breakup by Dosage Form:

Injectable

Oral

Topical

Others

Breakup by Application:

Oncology

Genetic Disorders

Neurology

Infectious Diseases

Respiratory

Cardiovascular

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Government and Academic Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy's Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global formulation development outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global formulation development outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the service?
  • What is the breakup of the market based on the dosage form?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global formulation development outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Formulation Development Outsourcing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Service

  • 6.1 Pre-formulation Services
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Discovery and Preclinical Services
      • 6.1.2.2 Analytical Services
    • 6.1.3 Market Forecast
  • 6.2 Formulation Optimization
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Phase I
      • 6.2.2.2 Phase II
      • 6.2.2.3 Phase III
      • 6.2.2.4 Phase IV
    • 6.2.3 Market Forecast

7 Market Breakup by Dosage Form

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Genetic Disorders
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Infectious Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Respiratory
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Cardiovascular
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Government and Academic Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Aizant Drug Research Solutions Private Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Catalent Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Charles River Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Emergent BioSolutions Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Intertek Group plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Irisys LLC (Recro Pharma)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Laboratory Corporation of America Holdings
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Pharma Solutions
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Quotient Sciences
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Syngene International Limited (Biocon Limited)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Thermo Fisher Scientific Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis